Quote:
Originally posted by Greedy,Greedy,Greedy
I deal with people researching and investing in the area all the time. Venture investors with a timeframe for exit that is absolutely limited to 10-12 years, and prefers 5-8 years, are eager to invest, but are nervious about the time frame and reviewing and staging potential investments accordingly. Like all biotech investments, there is a possibility of exit in 5-8 years based on having a late-stage product not yet approved for marketing for human treatment (in other words, as much as 2-3 years from market), but, that gives you a reasonable timeline tested in the marketplace for there being real treatments from this research within a decade.
|
this reads like something PPNYC wrote.
